Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2002-08-12 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ANNEMASSE (74100), Haute-Savoie
PHARMACIE PRINCIPALE D'ANNEMASSE : revenue, balance sheet and financial ratios
PHARMACIE PRINCIPALE D'ANNEMASSE is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ANNEMASSE (74100),
this company of category PME
shows in 2016 a revenue of 1.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PRINCIPALE D'ANNEMASSE (SIREN 443121124)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 894 200 €
1 800 243 €
1 821 389 €
Net income
83 226 €
116 452 €
135 947 €
200 916 €
71 845 €
119 700 €
124 551 €
95 523 €
132 729 €
158 831 €
160 082 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
182 844 €
222 829 €
223 584 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
7.0%
8.8%
8.8%
Revenue and income statement
In 2025, PHARMACIE PRINCIPALE D'ANNEMASSE generates positive net income of 83 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2014-2025: 160 k€ -> 83 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
83 226 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 18%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
18.381%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
76.996%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE PRINCIPALE D'ANNEMASSE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
16.385
3.006
3.636
2.371
0.538
0.495
0.477
1.879
0.331
0.67
18.381
Financial autonomy
71.245
83.042
83.032
83.969
87.332
89.999
89.156
86.442
90.429
90.683
76.996
Repayment capacity
0.669
0.194
0.346
None
None
None
None
None
None
None
None
Cash flow / Revenue
8.519%
8.633%
6.911%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
18.382025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Good
In 2025, the debt ratio of PHARMACIE PRINCIPALE D'AN... (18.38) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
77.0%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Excellent
In 2025, the financial autonomy of PHARMACIE PRINCIPALE D'AN... (77.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 647.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
647.842
Liquidity indicators evolution PHARMACIE PRINCIPALE D'ANNEMASSE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2014
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
114.115
164.37
227.989
294.069
355.433
482.073
472.298
437.755
609.724
672.931
647.842
Interest coverage
1.102
0.611
0.155
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
647.842025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Excellent
In 2025, the liquidity ratio of PHARMACIE PRINCIPALE D'AN... (647.84) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE PRINCIPALE D'ANNEMASSE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
255 341 €
274 429 €
308 925 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
54
57
59
0
0
0
0
0
0
0
0
Customer payment term (days)
0
0
0
0
0
0
0
0
0
0
0
Supplier payment term (days)
46
41
41
0
0
0
0
0
0
0
0
Positioning of PHARMACIE PRINCIPALE D'ANNEMASSE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE PRINCIPALE D'ANNEMASSE is estimated at
1 322 054 €
(range 897 152€ - 2 074 486€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
897k€1322k€2074k€
1 322 054 €Range: 897 152€ - 2 074 486€
NAF 5 année 2025
Valuation method used
Net Income Multiple
83 226 €
×
15.9x
=1 322 055 €
Range: 897 153€ - 2 074 486€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PRINCIPALE D'ANNEMASSE with other companies in the same sector:
Frequently asked questions about PHARMACIE PRINCIPALE D'ANNEMASSE
What is the revenue of PHARMACIE PRINCIPALE D'ANNEMASSE ?
The revenue of PHARMACIE PRINCIPALE D'ANNEMASSE in 2016 is 1.9 M€.
Is PHARMACIE PRINCIPALE D'ANNEMASSE profitable?
Yes, PHARMACIE PRINCIPALE D'ANNEMASSE generated a net profit of 83 k€ in 2025.
Where is the headquarters of PHARMACIE PRINCIPALE D'ANNEMASSE ?
The headquarters of PHARMACIE PRINCIPALE D'ANNEMASSE is located in ANNEMASSE (74100), in the department Haute-Savoie.
Where to find the tax return of PHARMACIE PRINCIPALE D'ANNEMASSE ?
The tax return of PHARMACIE PRINCIPALE D'ANNEMASSE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PRINCIPALE D'ANNEMASSE operate?
PHARMACIE PRINCIPALE D'ANNEMASSE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart